Pfizer INC Form 4 insider transactions

NYSE
Jennifer B. Damico, SVP & Controller of Pfizer Inc., reports the earn-out of stock appreciation rights and withholding of shares to cover tax obligations and exercise price.
NYSE
Pfizer's CEO, Albert Bourla, exercised stock appreciation rights and adjusted his holdings of Pfizer common stock on February 23, 2024.
NYSE
Executive Vice President Christoffel Boshoff reports multiple transactions involving Pfizer Inc. (PFE) common stock, including the exercise of stock appreciation rights and vesting of performance share awards.